BioRestorative Other Stockholder Equity from 2010 to 2025

BRTX Stock  USD 1.52  0.10  6.17%   
BioRestorative Therapies Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2025. During the period from 2010 to 2025, BioRestorative Therapies Other Stockholder Equity regression line of annual values had r-squared of  0.91 and arithmetic mean of  74,609,804. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2010-12-31
Previous Quarter
163.7 M
Current Value
164 M
Quarterly Volatility
61.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.7 M or Depreciation And Amortization of 178.1 K, as well as many indicators such as Price To Sales Ratio of 54.99, Dividend Yield of 0.0 or PTB Ratio of 0.69. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
  
Check out the analysis of BioRestorative Therapies Correlation against competitors.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of BioRestorative Therapies over the last few years. It is BioRestorative Therapies' Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

BioRestorative Other Stockholder Equity Regression Statistics

Arithmetic Mean74,609,804
Geometric Mean38,844,970
Coefficient Of Variation91.21
Mean Deviation58,616,773
Median55,269,490
Standard Deviation68,048,897
Sample Variance4630.7T
Range187M
R-Value0.96
Mean Square Error426.4T
R-Squared0.91
Slope13,665,070
Total Sum of Squares69459.8T

BioRestorative Other Stockholder Equity History

2025189.2 M
2024180.2 M
2023156.7 M
2022146.6 M
2021155.7 M
202088.2 M
201965.8 M

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity180.2 M189.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.